Caspases are a family of mammalian proteases related to the ced-3 gene of C
aenorhabditis elegans. They mediate many of the morphological and biochemic
al features of apoptosis, including structural dismantling of cell bodies a
nd nuclei, fragmentation of genomic DNA, destruction of regulatory proteins
, and propagation of other pro-apoptotic molecules. Based on their substrat
e specificities and DNA sequence homologies, the 14 currently identified ca
spases may be divided into three groups: apoptotic initiators, apoptotic ex
ecutioners, and inflammatory mediators. Caspases are activated through two
principal pathways, known as the "extrinsic pathway," which is initiated by
cell surface death receptor ligation, and the intrinsic pathway, which ari
ses from mitochondria. Endogenous inhibitors, such as the inhibitors of apo
ptosis (IAP) family, modulate caspase activity at various points within the
se pathways. Upon activation, caspases appear to play an important role in
sequelae of traumatic brain injury, spinal cord injury, and cerebral ischem
ia. In addition, they may also play a role in mediating cell death in chron
ic neurodegenerative conditions such as Alzheimer's disease, Huntington's d
isease, and amyotrophic lateral sclerosis. This article reviews the current
literature on the role of caspases in acute and chronic CNS injury, and pr
ovides evidence for the potential therapeutic use of caspase inhibitors in
the setting of these conditions.